A STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF SITAGLIPTIN/SIMVASTATIN FIXED-DOSE COMBINATION (FDC) IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH INADEQUATE GLYCEMIC CONTROL ON METFORMIN MONOTHERAPY (MK-0431D-312):